Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Accenture
Moodys
McKinsey
Medtronic
Boehringer Ingelheim
Novartis
US Department of Justice
Fuji
Farmers Insurance

Generated: February 18, 2018

DrugPatentWatch Database Preview

Bristol Company Profile

« Back to Dashboard

Summary for Bristol
International Patents:623
US Patents:23
Tradenames:87
Ingredients:74
NDAs:110
Drug Master File Entries: 1

Drugs and US Patents for Bristol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-002 Dec 20, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-005 Oct 9, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-002 Oct 31, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb REYATAZ atazanavir sulfate POWDER;ORAL 206352-001 Jun 2, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb SUSTIVA efavirenz CAPSULE;ORAL 020972-002 Sep 17, 1998 DISCN Yes No 6,939,964*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Bristol Myers Squibb REYATAZ atazanavir sulfate POWDER;ORAL 206352-001 Jun 2, 2014 RX Yes Yes 6,087,383*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Bristol Myers Squibb SPRYCEL dasatinib TABLET;ORAL 021986-002 Jun 28, 2006 AB RX Yes No 6,596,746 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Bristol PRECEF ceforanide INJECTABLE;INJECTION 050554-004 May 24, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb AMITID amitriptyline hydrochloride TABLET;ORAL 086454-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Bristol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991 5,616,566*PED ➤ Try a Free Trial
Bristol Myers Squibb ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020906-001 Feb 27, 1998 RE35524 ➤ Try a Free Trial
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET, TABLET, TABLET;ORAL 021387-004 Jun 24, 2003 5,180,589*PED ➤ Try a Free Trial
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-003 Apr 22, 1996 4,215,104 ➤ Try a Free Trial
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-003 Oct 9, 1991 5,616,566*PED ➤ Try a Free Trial
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 5,180,589*PED ➤ Try a Free Trial
Bristol Myers Squibb BARACLUDE entecavir TABLET;ORAL 021797-001 Mar 29, 2005 5,206,244*PED ➤ Try a Free Trial
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991 5,254,539*PED ➤ Try a Free Trial
Bristol Myers Squibb REYATAZ atazanavir sulfate POWDER;ORAL 206352-001 Jun 2, 2014 5,849,911*PED ➤ Try a Free Trial
Bristol Myers Squibb VIDEX EC didanosine CAPSULE, DELAYED REL PELLETS;ORAL 021183-002 Oct 31, 2000 5,254,539*PED ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for BRISTOL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 2.5 mg and 5 mg ➤ Subscribe 12/28/2016
➤ Subscribe Capsules 50 mg, 100 mg and 200 mg ➤ Subscribe 11/3/2016
➤ Subscribe Nasal Spray 4 mg/spray ➤ Subscribe 7/15/2016
➤ Subscribe Tablets 80 mg and 140 mg ➤ Subscribe 6/17/2011
➤ Subscribe Tablets 80 mg and 140 mg ➤ Subscribe 6/16/2011
➤ Subscribe Tablets 20 mg, 50 mg, 70 mg and 100 mg ➤ Subscribe 6/28/2010
➤ Subscribe Tablets 0.5 mg and 1 mg ➤ Subscribe 6/14/2010
➤ Subscribe Capsules 100 mg and 150 mg ➤ Subscribe 3/19/2010
➤ Subscribe Capsules 200 mg ➤ Subscribe 2/16/2010
➤ Subscribe Capsules 300 mg ➤ Subscribe 7/20/2009
➤ Subscribe Tablets 600 mg ➤ Subscribe 4/9/2009
➤ Subscribe Tablets 30 mg ➤ Subscribe 6/1/2005
➤ Subscribe Delayed-release Capsules 200 mg, 250 mg and 400 mg ➤ Subscribe 6/1/2004

Non-Orange Book US Patents for Bristol

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,139,541 Modulators of pharmacokinetic properties of therapeutics ➤ Try a Free Trial
9,227,961 Hepatitis C virus inhibitors ➤ Try a Free Trial
6,979,694 Cyclic protein tyrosine kinase inhibitors ➤ Try a Free Trial
7,960,411 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors ➤ Try a Free Trial
6,989,391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors ➤ Try a Free Trial
7,371,761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors ➤ Try a Free Trial
7,531,535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors ➤ Try a Free Trial
5,965,729 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent ➤ Try a Free Trial
RE38629 Solid oral dosage form comprising a combination of metformin and glibenclamide ➤ Try a Free Trial
8,088,770 Modulators of pharmacokinetic properties of therapeutics ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Bristol Drugs

Supplementary Protection Certificates for Bristol Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014 00037 Denmark ➤ Try a Free Trial PRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116
2015 00060 Denmark ➤ Try a Free Trial PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/13/830/001-002 20130527
2016040 Lithuania ➤ Try a Free Trial PRODUCT NAME: DARUNAVIRAS + KOBICISTATAS; REGISTRATION NO/DATE: EU/1/14/967 20141119
0713 Netherlands ➤ Try a Free Trial PRODUCT NAME: DACLATASVIR EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN, IN HET BIJZONDER DACLATASVIR DIHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/14/939/001-004 20140826
C/GB11/042 United Kingdom ➤ Try a Free Trial PRODUCT NAME: APIXABAN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/11/691/001 20110520; UK EU/1/11/691/002 20110520; UK EU/1/11/691/003 20110520; UK EU/1/11/691/004 20110520; UK EU/1/11/691/005 20110520
2016 00016 Denmark ➤ Try a Free Trial PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
90027-1 Sweden ➤ Try a Free Trial PRODUCT NAME: AZTREONAMLYSIN; REG. NO/DATE: EU/1/09/543/01 20090921
2 5024-2015 Slovakia ➤ Try a Free Trial PRODUCT NAME: KOBICISTAT VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/13/830 20130527
00597 Netherlands ➤ Try a Free Trial PRODUCT NAME: INSULINE DEGLUDEC EN INSULINE ASPART; REGISTRATION NO/DATE: EU/1/12/806/001EU/1/12/806/004EU/1/12/806/005EU/1/12/806/007EU/1/12/806/008 2013210121
15/058 Ireland ➤ Try a Free Trial PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/830/001-EU/1/13/830/002 20130524
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Federal Trade Commission
McKesson
Farmers Insurance
Baxter
Fuji
Cerilliant
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot